Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of Vermox Chewable (Mebendazole) tablets for the treatment of children and adults with roundworm and whipworm infections

Next Previous
Trial Profile

A study of Vermox Chewable (Mebendazole) tablets for the treatment of children and adults with roundworm and whipworm infections

Status: Completed
Phase of Trial: Phase II/III

Latest Information Update: 19 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mebendazole (Primary)
  • Indications Helminthiasis
  • Focus Therapeutic Use

    • Most Recent Events

    • 09 Nov 2016 New trial record
    • 19 Oct 2016 According to a Janssen media release, the U.S. Food and Drug Administration (FDA) has approved Vermos (mebendazole) chewable 500mg tablets for the treatment of patients one year of age and older with gastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura(whipworm)
    • 19 Oct 2016 Results published in the Media Release
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top